Delivery Order SPE2DB24D1021-SPE2DB24FEUAU

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medication. The contract has a ceiling value of $1,878.64 and a period of performance through March 6, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,150.65. The contract is not set aside and is a firm fixed price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $2,733.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to support government healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,401.33 Firm Fixed Price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract has an ultimate completion date of July 8, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,068.84 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The award, valued at $3,491.35, is a firm fixed-price contract with an ultimate completion date of August 24, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The $2,476.44 fixed-price contract has a completion date of September 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) awarded a $3,654.42 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which covers a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract (SPE2DX15D3015|SPE2DX24F0GR0) by the Defense Logistics Agency (DLA) Troop Support Medical to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The award has a ceiling value of $2,495.23 and a period of performance through March 25, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The award has a ceiling value of $1,187.60 and an ultimate completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military treatment facilities and other...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUAU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, at a ceiling value of $2,778.77. The delivery order is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen leverages its extensive supply chain to provide essential pharmaceutical and medical products to various defense and civilian federal agencies and healthcare programs.

Generated 12/11/24, 9:17 AM